Determinants of systemic anticancer treatment and continuous intravenous opioid and/or benzodiazepine use at end of life: A real-world analysis of demographic and clinical factors in advanced cancer patients
Determinants of systemic anticancer treatment and continuous intravenous opioid and/or benzodiazepine use at end of life: A real-world analysis of demographic and clinical factors in advanced cancer patients. // Clinical Medicine. – URL: https://www.sciencedirect.com/science/article/pii/S1470211826001211?dgcid=rss_sd_all
Determinants of systemic anticancer treatment and continuous intravenous opioid and/or benzodiazepine use at end of life: A real-world analysis of demographic and clinical factors in advanced cancer patients. Clinical Medicine. https://www.sciencedirect.com/science/article/pii/S1470211826001211?dgcid=rss_sd_all
“Determinants of systemic anticancer treatment and continuous intravenous opioid and/or benzodiazepine use at end of life: A real-world analysis of demographic and clinical factors in advanced cancer patients.” Clinical Medicine.
@article{article40923,
title = {Determinants of systemic anticancer treatment and continuous intravenous opioid and/or benzodiazepine use at end of life: A real-world analysis of demographic and clinical factors in advanced cancer patients},
journal = {Clinical Medicine},
url = {https://www.sciencedirect.com/science/article/pii/S1470211826001211?dgcid=rss_sd_all}
}
ABSTRACT As leadership education continues to evolve, increasing attention has been given to fostering learners’ leadership identity, capacity, and efficacy. Drawing on collaborative conversations with 12 leadership educators...